Showing posts with label Stem Cell Therapy Market. Show all posts
Showing posts with label Stem Cell Therapy Market. Show all posts

Sunday, 28 January 2018

Global Stem Cell Therapy Market To Grow At A CAGR Of 36.52% During The Period 2017-2021

Researchmoz added Most up-to-date research on "Global Stem Cell Therapy Market 2017-2021" to its huge collection of research reports.

Stem cell therapy is the use of stem cells for the treatment or prevention of a disease or condition. Bone marrow transplant is the widely-used stem cell therapy, followed by therapies derived from umbilical cord blood. Research is being undertaken to develop various sources (such as cord blood cells, bone marrow, and skin) for stem cells, and to apply them to various disorders like neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions.

Technavios analysts forecast the global stem cell therapy market to grow at a CAGR of 36.52% during the period 2017-2021.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=964335

Covered in this report
The report covers the present scenario and the growth prospects of the global stem cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of stem cell therapy products/segments in the market.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Global Stem Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Holostem Advanced Therapies
JCR Pharmaceuticals
Organogenesis
Osiris Therapeutics
Vericel
Other prominent vendors
AbbVie
American CryoStem
AM-Pharma
Anterogen
apceth Biopharma
Astellas Pharma
Athersys
Baxter International
Beike Biotechnology
BIOTIME
bluebird bio
Bristol-Myers Squibb
BrainStorm Cell Therapeutics
Brainxell
Caladrius Biosciences
Cellular Biomedicine Group
Cellular Dynamics International (a subsidiary of Fujifilm)
Cesca Therapeutics
CHA Biotech
Chugai Pharmaceutical
Citospin
Corestem
Cytori Therapeutics
Daiichi Sankyo
Fujifilm
Gamida Cell
Global Stem Cells Group
Grupo Ferrer Internacional
GlaxoSmithKline
Hemostemix
Histocell
International Stem Cell
Ivy Institute of Stem Cells
Japan Regenerative Medicine
Kangstem Biotech
Kiadis Pharma
Laboratorios Salvat
MEDIPOST
Mesoblast
Nuo Therapeutics
Opsis Therapeutics
Osiris Therapeutics
Pharmicell
Pluristem Therapeutics
Promethera Biosciences
Q Therapeutics
ReNeuron
RHEACELL
Salus Medical Solutions
Sangamo Therapeutics
Shire
Steminent Biotherapeutics
Sumitomo Dainippon Pharma
Taiwan Bio Therapeutics
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Thoratec Corporation
TiGenix
Translational Biosciences
TWO CELLS
U.S. Stem Cell
ViaCyte
VistaGen Therapeutics

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-stem-cell-therapy-market-2017-2021-report.html/toc

Market driver
Increase in federal funding in stem cell therapy
For a full, detailed list, view our report

Market challenge
Stringent regulatory environment affecting the product approvals
For a full, detailed list, view our report

Market trend
Evolution of new destinations in the development of stem cell therapies
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Thursday, 25 January 2018

Asia-Pacific Stem Cell Therapy Market Key Trends, Size, Growth, Shares And Forecast Report 2017

Researchmoz added Most up-to-date research on "Asia-Pacific Stem Cell Therapy Market Report 2017" to its huge collection of research reports.

In this report, the Asia-Pacific Stem Cell Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Stem Cell Therapy for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1376739

Asia-Pacific Stem Cell Therapy market competition by top manufacturers/players, with Stem Cell Therapy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Celgene
Guanhao Biotech
Mesoblast
Vericel Corporation
Stemcell Technologes
Beike Biotechnology
Cytori Therapeutics
Bioheart
Pluristem Therapeutics
Fibrocell Science
Ocata Therapeutics
Athersys
Geron

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
Autologous
Allogeneic

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
CNS
CVS
GIT
Wounds and Injuries
Others

Table of Contents

Asia-Pacific Stem Cell Therapy Market Report 2017
1 Stem Cell Therapy Overview
1.1 Product Overview and Scope of Stem Cell Therapy
1.2 Classification of Stem Cell Therapy by Product Category
1.2.1 Asia-Pacific Stem Cell Therapy Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Stem Cell Therapy Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Autologous
1.2.4 Allogeneic
1.3 Asia-Pacific Stem Cell Therapy Market by Application/End Users
1.3.1 Asia-Pacific Stem Cell Therapy Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 CNS
1.3.3 CVS
1.3.4 GIT
1.3.5 Wounds and Injuries
1.3.6 Others
1.4 Asia-Pacific Stem Cell Therapy Market by Region
1.4.1 Asia-Pacific Stem Cell Therapy Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Stem Cell Therapy (2012-2022)
1.5.1 Asia-Pacific Stem Cell Therapy Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Stem Cell Therapy Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Stem Cell Therapy Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Stem Cell Therapy Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Stem Cell Therapy Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Stem Cell Therapy Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Stem Cell Therapy (Volume and Value) by Type
2.2.1 Asia-Pacific Stem Cell Therapy Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Stem Cell Therapy Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Stem Cell Therapy (Volume) by Application
2.4 Asia-Pacific Stem Cell Therapy (Volume and Value) by Region
2.4.1 Asia-Pacific Stem Cell Therapy Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Stem Cell Therapy Revenue and Market Share by Region (2012-2017)

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/asia-pacific-stem-cell-therapy-market-report-2017-report.html/toc

3 China Stem Cell Therapy (Volume, Value and Sales Price)
3.1 China Stem Cell Therapy Sales and Value (2012-2017)
3.1.1 China Stem Cell Therapy Sales Volume and Growth Rate (2012-2017)
3.1.2 China Stem Cell Therapy Revenue and Growth Rate (2012-2017)
3.1.3 China Stem Cell Therapy Sales Price Trend (2012-2017)
3.2 China Stem Cell Therapy Sales Volume and Market Share by Type
3.3 China Stem Cell Therapy Sales Volume and Market Share by Application

4 Japan Stem Cell Therapy (Volume, Value and Sales Price)
4.1 Japan Stem Cell Therapy Sales and Value (2012-2017)
4.1.1 Japan Stem Cell Therapy Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Stem Cell Therapy Revenue and Growth Rate (2012-2017)
4.1.3 Japan Stem Cell Therapy Sales Price Trend (2012-2017)
4.2 Japan Stem Cell Therapy Sales Volume and Market Share by Type
4.3 Japan Stem Cell Therapy Sales Volume and Market Share by Application

5 South Korea Stem Cell Therapy (Volume, Value and Sales Price)
5.1 South Korea Stem Cell Therapy Sales and Value (2012-2017)
5.1.1 South Korea Stem Cell Therapy Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Stem Cell Therapy Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Stem Cell Therapy Sales Price Trend (2012-2017)
5.2 South Korea Stem Cell Therapy Sales Volume and Market Share by Type
5.3 South Korea Stem Cell Therapy Sales Volume and Market Share by Application

6 Taiwan Stem Cell Therapy (Volume, Value and Sales Price)
6.1 Taiwan Stem Cell Therapy Sales and Value (2012-2017)
6.1.1 Taiwan Stem Cell Therapy Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Stem Cell Therapy Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Stem Cell Therapy Sales Price Trend (2012-2017)
6.2 Taiwan Stem Cell Therapy Sales Volume and Market Share by Type
6.3 Taiwan Stem Cell Therapy Sales Volume and Market Share by Application

Continue...

Stem Cell Therapy Asia-Pacific Market Analysis 2017 | Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Celgene

Researchmoz added Most up-to-date research on "Asia-Pacific Stem Cell Therapy Market Report 2017" to its huge collection of research reports.

In this report, the Asia-Pacific Stem Cell Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Stem Cell Therapy for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1376739

Asia-Pacific Stem Cell Therapy market competition by top manufacturers/players, with Stem Cell Therapy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Celgene
Guanhao Biotech
Mesoblast
Vericel Corporation
Stemcell Technologes
Beike Biotechnology
Cytori Therapeutics
Bioheart
Pluristem Therapeutics
Fibrocell Science
Ocata Therapeutics
Athersys
Geron

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
Autologous
Allogeneic

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
CNS
CVS
GIT
Wounds and Injuries
Others

Table of Contents

Asia-Pacific Stem Cell Therapy Market Report 2017
1 Stem Cell Therapy Overview
1.1 Product Overview and Scope of Stem Cell Therapy
1.2 Classification of Stem Cell Therapy by Product Category
1.2.1 Asia-Pacific Stem Cell Therapy Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Stem Cell Therapy Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Autologous
1.2.4 Allogeneic
1.3 Asia-Pacific Stem Cell Therapy Market by Application/End Users
1.3.1 Asia-Pacific Stem Cell Therapy Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 CNS
1.3.3 CVS
1.3.4 GIT
1.3.5 Wounds and Injuries
1.3.6 Others
1.4 Asia-Pacific Stem Cell Therapy Market by Region
1.4.1 Asia-Pacific Stem Cell Therapy Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Stem Cell Therapy (2012-2022)
1.5.1 Asia-Pacific Stem Cell Therapy Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Stem Cell Therapy Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Stem Cell Therapy Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Stem Cell Therapy Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Stem Cell Therapy Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Stem Cell Therapy Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Stem Cell Therapy (Volume and Value) by Type
2.2.1 Asia-Pacific Stem Cell Therapy Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Stem Cell Therapy Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Stem Cell Therapy (Volume) by Application
2.4 Asia-Pacific Stem Cell Therapy (Volume and Value) by Region
2.4.1 Asia-Pacific Stem Cell Therapy Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Stem Cell Therapy Revenue and Market Share by Region (2012-2017)

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/asia-pacific-stem-cell-therapy-market-report-2017-report.html/toc

3 China Stem Cell Therapy (Volume, Value and Sales Price)
3.1 China Stem Cell Therapy Sales and Value (2012-2017)
3.1.1 China Stem Cell Therapy Sales Volume and Growth Rate (2012-2017)
3.1.2 China Stem Cell Therapy Revenue and Growth Rate (2012-2017)
3.1.3 China Stem Cell Therapy Sales Price Trend (2012-2017)
3.2 China Stem Cell Therapy Sales Volume and Market Share by Type
3.3 China Stem Cell Therapy Sales Volume and Market Share by Application

4 Japan Stem Cell Therapy (Volume, Value and Sales Price)
4.1 Japan Stem Cell Therapy Sales and Value (2012-2017)
4.1.1 Japan Stem Cell Therapy Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Stem Cell Therapy Revenue and Growth Rate (2012-2017)
4.1.3 Japan Stem Cell Therapy Sales Price Trend (2012-2017)
4.2 Japan Stem Cell Therapy Sales Volume and Market Share by Type
4.3 Japan Stem Cell Therapy Sales Volume and Market Share by Application

5 South Korea Stem Cell Therapy (Volume, Value and Sales Price)
5.1 South Korea Stem Cell Therapy Sales and Value (2012-2017)
5.1.1 South Korea Stem Cell Therapy Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Stem Cell Therapy Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Stem Cell Therapy Sales Price Trend (2012-2017)
5.2 South Korea Stem Cell Therapy Sales Volume and Market Share by Type
5.3 South Korea Stem Cell Therapy Sales Volume and Market Share by Application

6 Taiwan Stem Cell Therapy (Volume, Value and Sales Price)
6.1 Taiwan Stem Cell Therapy Sales and Value (2012-2017)
6.1.1 Taiwan Stem Cell Therapy Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Stem Cell Therapy Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Stem Cell Therapy Sales Price Trend (2012-2017)
6.2 Taiwan Stem Cell Therapy Sales Volume and Market Share by Type
6.3 Taiwan Stem Cell Therapy Sales Volume and Market Share by Application

Continue...

Tuesday, 22 November 2016

Global Stem Cell Therapy Market Outlook 2016-2021 Industry Key Trends, Size, Growth, Shares And Forecast Research Report

Researchmoz added Most up-to-date research on "Global Stem Cell Therapy Market Outlook 2016-2021" to its huge collection of research reports.

Gen's report, 'Global Stem Cell Therapy Market Outlook 2016-2021' provides detailed market and segment level data on the Global and Chinese consumption of Stem Cell Therapy. The report provides historic, forecast and growth patterns by company, country and type/application from 2016 to 2021.

This report delivers an extensive overview of Global Stem Cell Therapy industry with a focus on China. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. It also helps the companies to better understand the trends of Soups market to seize opportunities and formulate crucial business strategies.
With this report, you will get access to:

1. Market overview including definition, industrial chain (upstream & downstream), manufacturing technology details and the costs analysis from the aspects of raw materials, labor costs and depreciation.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=651652

2. Value and volume consumption status and trends of the market, including Global and Chinese top players capacity & production, price & production value, cost & profit and market shares from 2011 to 2016.3. Worldwide supply/demand pattern of Stem Cell Therapy by country or region (North America, China, EMEA, Asia except China), and by application/type.

4. Growth, trends and forecast of 2016-2021 Stem Cell Therapy market and some important proposals for new investment of Stem Cell Therapy Industry before evaluating its feasibility.

Overall, the report provides an in-depth insight of 2011-2021 Global and Chinese Stem Cell Therapy industry covering all important parameters.

Table Of Content

Chapter One Description
1.1 Study Scope
1.2 Key Findings of Industry

Chapter Two Brief Introduction
2.1 Definition
2.2 Industry Chain Structure
2.2.1 Upstream Raw Materials
2.2.2 Downstream Market

Chapter Three Development and Trends
3.1 Key Manufacturing Technologies
3.2 Issues and Trends

Chapter Four Cost Structure
4.1 Bill of Materials (BOM)
4.3 Labor Costs
4.4 Depreciation Costs
4.5 Manufacturing Costs

Chapter Five Worldwide Key Vendors
Company A
Company B
Company C
Company D
Company E
Company F
Company G

Chapter Six Market Overview
6.1 Global Market Size
6.2 Chinese Market Size

Chapter Seven Market Status
7.1 Market Competition Status by Key Vendors
7.2 Regional Market Competition Status
China
North American
EMEA
Asia except China

Chapter Eight Consumption Pattern
8.1 Regional Consumption
8.2 Global Consumption by Application
8.3 Chinese Consumption by Application

Chapter Nine Market Forecast
9.1 Market Size Forecast
9.2 Regional Consumption Forecast
9.3 Global Consumption Forecast by Application
9.4 Chinese Consumption Forecast by Application

Chapter Ten Development/Trends
10.1 Policies and Events
10.2 2015 New Situation

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=651652

Wednesday, 9 November 2016

New Survey Reveals Global Stem Cell Therapy Market Outlook 2016-2021 | Researchmoz.us

Researchmoz added Most up-to-date research on "Global Stem Cell Therapy Market Outlook 2016-2021" to its huge collection of research reports.

'Global Stem Cell Therapy Market Outlook 2016-2021' provides detailed market and segment level data on the Global and Chinese consumption of Stem Cell Therapy. The report provides historic, forecast and growth patterns by company, country and type/application from 2016 to 2021.

This report delivers an extensive overview of Global Stem Cell Therapy industry with a focus on China. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. It also helps the companies to better understand the trends of Soups market to seize opportunities and formulate crucial business strategies.
With this report, you will get access to:

1. Market overview including definition, industrial chain (upstream & downstream), manufacturing technology details and the costs analysis from the aspects of raw materials, labor costs and depreciation.

2. Value and volume consumption status and trends of the market, including Global and Chinese top players capacity & production, price & production value, cost & profit and market shares from 2011 to 2016.

3. Worldwide supply/demand pattern of Stem Cell Therapy by country or region (North America, China, EMEA, Asia except China), and by application/type.

4. Growth, trends and forecast of 2016-2021 Stem Cell Therapy market and some important proposals for new investment of Stem Cell Therapy Industry before evaluating its feasibility.

Overall, the report provides an in-depth insight of 2011-2021 Global and Chinese Stem Cell Therapy industry covering all important parameters.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=651652

Table Of Content

Chapter One Description
1.1 Study Scope
1.2 Key Findings of Industry

Chapter Two Brief Introduction
2.1 Definition
2.2 Industry Chain Structure
2.2.1 Upstream Raw Materials
2.2.2 Downstream Market

Chapter Three Development and Trends
3.1 Key Manufacturing Technologies
3.2 Issues and Trends

Chapter Four Cost Structure
4.1 Bill of Materials (BOM)
4.3 Labor Costs
4.4 Depreciation Costs
4.5 Manufacturing Costs

Chapter Five Worldwide Key Vendors
Company A
Company B
Company C
Company D
Company E
Company F
Company G

Chapter Six Market Overview
6.1 Global Market Size
6.2 Chinese Market Size

Chapter Seven Market Status
7.1 Market Competition Status by Key Vendors
7.2 Regional Market Competition Status
China
North American
EMEA
Asia except China

Chapter Eight Consumption Pattern
8.1 Regional Consumption
8.2 Global Consumption by Application
8.3 Chinese Consumption by Application

Chapter Nine Market Forecast
9.1 Market Size Forecast
9.2 Regional Consumption Forecast
9.3 Global Consumption Forecast by Application
9.4 Chinese Consumption Forecast by Application

Chapter Ten Development/Trends
10.1 Policies and Events
10.2 2015 New Situation

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=651652

Blood Thawing System Market Insights Shared in Detailed Report

Blood Thawing System Market: Introduction According to the report, the global  blood thawing system market  was valued at ~US$ 174 Mn in 2...